This new eight-episode educational video series will examine the latest efforts to respond to the COVID-19 pandemic and break down the complex process of developing a vaccine.

Each week our host Lisa Ling will talk to leading scientists and researchers, healthcare workers on the front lines and public health experts around the world working collaboratively to help bring an end to the deadly pandemic.
Live
Live at 12 PM EDT on Tuesdays
Tune in on JNJ.com, Facebook, LinkedIn or Twitter. Come back to this page at any time to watch a replay.
Episode 7
What Our “New Normal” Might Look Like Until We Get a COVID-19 Vaccine
In Episode 7, Lisa Ling speaks with Johnson & Johnson Chief Scientific Officer Paul Stoffels, M.D., about important advances being made in vaccine development. Former FDA Commissioner Mark McClellan, M.D., Ph.D., discusses what reopening could look like and global health leader Jonathan Quick, M.D., MPH, shares why he believes testing is critical to help manage this pandemic.
What Our “New Normal” Might Look Like Until We Get a COVID-19 Vaccine
What Our “New Normal” Might Look Like Until We Get a COVID-19 Vaccine

All Episodes

    Episode 1
    April 14, 2020
    Join host Lisa Ling as she interviews scientists and healthcare workers about how vaccines work, the impact of the COVID-19 pandemic and what’s being done globally to create a novel coronavirus vaccine.
    How a COVID-19 Vaccine Might Work. Plus, How Quickly We Could Get There
    How a COVID-19 Vaccine Might Work. Plus, How Quickly We Could Get There
    Episode 2
    April 21, 2020
    Three leading scientists who have been on the frontlines of Zika, malaria and HIV give you the inside scoop on vaccine development and the process of going from lab to clinic.
    What it Takes to Create a Coronavirus Vaccine in Record Time
    What it Takes to Create a Coronavirus Vaccine in Record Time
    Episode 3
    April 28, 2020
    Lisa Ling interviews National Academies member and University Professor at the University of Connecticut, Cato Laurencin, M.D., Ph.D., to learn what his new coronavirus study reveals. Plus, what’s needed to mass-produce a vaccine and what we’ve learned from other outbreaks.
    Why is COVID-19 Hitting Minority Communities So Hard?
    Why is COVID-19 Hitting Minority Communities So Hard?
    Episode 4
    May 05, 2020
    This week we hear from two ER doctors about what they’ve learned from caring for COVID-19 patients. A renowned epidemiologist shares why testing is so important. A Nigerian doctor who recovered from Ebola herself talks about how fighting this outbreak is different. Plus, a leading scientist talks about how long vaccine immunity could last.
    What Doctors On The Front Lines of COVID-19 Are Now Saying About the Virus
    What Doctors On The Front Lines of COVID-19 Are Now Saying About the Virus
    Episode 5
    May 12, 2020
    Two nurses—one on the front lines in the ICU, and one leading the charge to advocate for her profession—talk about what caring for patients, and each other, really means right now. An activist talks about recovering from the virus and a scientist shares the challenges of creating a vaccine for clinical. Plus, Arianna Huffington and Husseini K. Manji, MD, FRCPC, discuss the other COVID-19 crisis: how it's impacting mental health.
    How Nurses Are Battling the COVID-19 Pandemic
    How Nurses Are Battling the COVID-19 Pandemic
    Episode 6
    May 19, 2020
    Lisa Ling speaks with the Chair of the Coalition for Epidemic Preparedness Innovations, a supply chain expert and the President of Global Public Affairs at UPS about what it will take to get a vaccine to the people who need it. Plus, a young Nigerian activist on her outreach efforts.
    How the Global Community is Coming Together to Battle COVID-19
    How the Global Community is Coming Together to Battle COVID-19
    Episode 7
    May 26, 2020
    In Episode 7, Lisa Ling speaks with Johnson & Johnson Chief Scientific Officer Paul Stoffels, M.D., about important advances being made in vaccine development. Former FDA Commissioner Mark McClellan, M.D., Ph.D., discusses what reopening could look like and global health leader Jonathan Quick, M.D., MPH, shares why he believes testing is critical to help manage this pandemic.
    What Our “New Normal” Might Look Like Until We Get a COVID-19 Vaccine
    What Our “New Normal” Might Look Like Until We Get a COVID-19 Vaccine
Meet Our Host
Ling is the Executive Producer and host of This Is Life on CNN. She has also been a field correspondent for The Oprah Winfrey Show and a contributor to ABC News' Nightline.
Episode 7: Special Expert Guest
Dr. McClellan is Director—and the Robert J. Margolis Professor of Business, Medicine and Policy—at the Duke-Margolis Center for Health Policy at Duke University. He is at the center of the nation’s efforts to combat the pandemic and the co-author of a roadmap that details the steps needed for a comprehensive COVID-19 response and safe reopening of our country.
Episode 7: Special Expert Guest
Dr. Quick is the Managing Director of Pandemic Response, Preparedness and Prevention at The Rockefeller Foundation. He has extensive experience in international public health, including with the World Health Organization, Management Sciences for Health and the Duke Global Health Institute. He is the author of The End of Epidemics: The Looming Threat to Humanity and How to Stop It.
Episode 7: J&J Expert Guest
Dr. Stoffels is the Vice Chairman of the Executive Committee and Chief Scientific Officer at Johnson & Johnson. He spearheads the research and product pipeline by leading teams across all of the company's sectors to set the company-wide innovation agenda, discovering and developing transformational healthcare solutions.
At the height of the outbreak in New York City, Dr. Ed Kuffner took a leave of absence from his job to volunteer at a Brooklyn hospital hard hit by the pandemic. He shares what the experience taught him about his own strengths—and ideas for coping during this unprecedented time.
  • What People Are Saying

      Excellent speakers. It gives a good perspective on what the nurses are dealing with. Thank you!

      Such an awesome episode!! Great panelists!!! Happy Nurses day to all nurses, especially my sister!!!

      Glad to see how leaders from J&J are supporting front liners, which is an incredible example of serving community as a first priority. Many thanks.

      Wonderful guests—thank you!

      Thank you Lisa for doing these interviews and the J&J team for providing this information. Your calm, thoughtful approach to covering these complex multi-dimensional issues is so appreciated.🌼

      Best wishes, Dr. Schuitemaker. Thanks for all the hard work, conducting number of trial activities in parallel and collaborating across the industry.

      Appreciate all the hard work of our scientists, sacrificing so much of their time. You guys are heroes!

      Amazing, we value your countless contributions to saving lives.

      Looking forward to tuning in to tomorrow's episode. Appreciate these very informative sessions. Thanks, Lisa!

      It is really brilliant to see that Johnson and Johnson are gearing up for production worldwide for the vaccines once approved by PHE.

      I love my company, worked a lot of years being an inspector. Miss not working, I'm retired now. They will find a vaccine.

      The Human Genome Project began with the same spirit. Well done J&J for reviving that collaborative working.

  • Submit a Question
    Do you have a question that you would like to have answered on an upcoming episode of The Road to a Vaccine?
This site uses cookies as described in our Cookie Policy. Please click the "Accept" button or continue to use our site if you agree to our use of cookies.
You are now leaving jnj.com. The site you’re being redirected to is a branded pharmaceutical website. Please click below to continue to that site.
Continue